Newly Diagnosed Clinical Trials in Fuzhou, Fujian
2 recruitingFuzhou, Fujian, China
Showing 1–2 of 2 trials
Recruiting
Phase 4
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
Acute Myeloid LeukemiaChemotherapy EffectNewly Diagnosed
Fujian Medical University Union Hospital100 enrolled1 locationNCT07561892
Recruiting
Phase 4
Two Regimens of IVIG in the Treatment of Newly Diagnosed ITP in Children
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Fujian Medical University Union Hospital580 enrolled1 locationNCT05520892